A Controlled Trial of Renal Denervation for Resistant Hypertension
The SYMPLICITY HTN-3 trial did not show a significant reduction of systolic blood pressure in patients with resistant hypertension 6 months after renal-artery denervation as compared with a sham control.
:
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Treatment blood pressure targets for hypertension.
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Clinical Trial Results Hypertension Source Type: research